questionsmedicales.fr
Régions géographiques
Asie
Asie du Sud-Est
Vietnam
Vietnam : Questions médicales fréquentes
Termes MeSH sélectionnés :
Protein Processing, Post-Translational
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vietnam : Questions médicales les plus fréquentes",
"headline": "Vietnam : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vietnam : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-12",
"dateModified": "2025-05-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vietnam"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Asie du Sud-Est",
"url": "https://questionsmedicales.fr/mesh/D001210",
"about": {
"@type": "MedicalCondition",
"name": "Asie du Sud-Est",
"code": {
"@type": "MedicalCode",
"code": "D001210",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.252.145"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Vietnam",
"alternateName": "Vietnam",
"code": {
"@type": "MedicalCode",
"code": "D014744",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Pham Quang Thai",
"url": "https://questionsmedicales.fr/author/Pham%20Quang%20Thai",
"affiliation": {
"@type": "Organization",
"name": "National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam; School of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Viet Nam."
}
},
{
"@type": "Person",
"name": "Le Van Tan",
"url": "https://questionsmedicales.fr/author/Le%20Van%20Tan",
"affiliation": {
"@type": "Organization",
"name": "Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam."
}
},
{
"@type": "Person",
"name": "Marc Choisy",
"url": "https://questionsmedicales.fr/author/Marc%20Choisy",
"affiliation": {
"@type": "Organization",
"name": "Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; Centre for Global Health and Tropical Medicine, University of Oxford, UK."
}
},
{
"@type": "Person",
"name": "H Rogier van Doorn",
"url": "https://questionsmedicales.fr/author/H%20Rogier%20van%20Doorn",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "H T Nguyen",
"url": "https://questionsmedicales.fr/author/H%20T%20Nguyen",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A Chemical Mutagenesis Approach to Insert Post-translational Modifications in Aggregation-Prone Proteins.",
"datePublished": "2022-05-24",
"url": "https://questionsmedicales.fr/article/35609278",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acschemneuro.2c00077"
}
},
{
"@type": "ScholarlyArticle",
"name": "Post-Translational Modifications of Proteins in Cytosolic Nucleic Acid Sensing Signaling Pathways.",
"datePublished": "2022-06-20",
"url": "https://questionsmedicales.fr/article/35795661",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.898724"
}
},
{
"@type": "ScholarlyArticle",
"name": "Modeling Side Chains in the Three-Dimensional Structure of Proteins for Post-Translational Modifications.",
"datePublished": "2023-08-30",
"url": "https://questionsmedicales.fr/article/37686234",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241713431"
}
},
{
"@type": "ScholarlyArticle",
"name": "Multi-protein assemblies orchestrate co-translational enzymatic processing on the human ribosome.",
"datePublished": "2024-09-03",
"url": "https://questionsmedicales.fr/article/39227397",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41467-024-51964-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Protein Kinases and Cross-talk between Post-translational Modifications in the Regulation of Drug Transporters.",
"datePublished": "2022-10-27",
"url": "https://questionsmedicales.fr/article/36302660",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1124/molpharm.122.000604"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Régions géographiques",
"item": "https://questionsmedicales.fr/mesh/D005842"
},
{
"@type": "ListItem",
"position": 3,
"name": "Asie",
"item": "https://questionsmedicales.fr/mesh/D001208"
},
{
"@type": "ListItem",
"position": 4,
"name": "Asie du Sud-Est",
"item": "https://questionsmedicales.fr/mesh/D001210"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vietnam",
"item": "https://questionsmedicales.fr/mesh/D014744"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vietnam - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vietnam",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vietnam",
"description": "Comment diagnostiquer la dengue au Vietnam ?\nQuels tests pour le paludisme au Vietnam ?\nComment identifier la tuberculose ?\nQuels signes pour le choléra ?\nComment détecter une infection à VIH ?",
"url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Protein+Processing,+Post-Translational&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vietnam",
"description": "Quels symptômes de la dengue ?\nQuels signes du paludisme ?\nQuels symptômes de la tuberculose ?\nQuels signes du choléra ?\nQuels symptômes d'une infection à VIH ?",
"url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Protein+Processing,+Post-Translational&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vietnam",
"description": "Comment prévenir la dengue ?\nQuelles mesures pour prévenir le paludisme ?\nComment prévenir la tuberculose ?\nQuelles précautions contre le choléra ?\nComment prévenir le VIH ?",
"url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Protein+Processing,+Post-Translational&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vietnam",
"description": "Quel traitement pour la dengue ?\nComment traiter le paludisme ?\nQuel traitement pour la tuberculose ?\nComment traiter le choléra ?\nQuel traitement pour le VIH ?",
"url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Protein+Processing,+Post-Translational&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vietnam",
"description": "Quelles complications de la dengue ?\nQuelles complications du paludisme ?\nQuelles complications de la tuberculose ?\nQuelles complications du choléra ?\nQuelles complications du VIH ?",
"url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Protein+Processing,+Post-Translational&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vietnam",
"description": "Quels facteurs de risque pour la dengue ?\nQuels facteurs de risque pour le paludisme ?\nQuels facteurs de risque pour la tuberculose ?\nQuels facteurs de risque pour le choléra ?\nQuels facteurs de risque pour le VIH ?",
"url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Protein+Processing,+Post-Translational&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la dengue au Vietnam ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins pour détecter les anticorps ou l'ARN viral."
}
},
{
"@type": "Question",
"name": "Quels tests pour le paludisme au Vietnam ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un frottis sanguin ou un test de diagnostic rapide sont utilisés pour le paludisme."
}
},
{
"@type": "Question",
"name": "Comment identifier la tuberculose ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "La tuberculose est diagnostiquée par des tests cutanés, des radiographies et des cultures."
}
},
{
"@type": "Question",
"name": "Quels signes pour le choléra ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le choléra se diagnostique par des selles liquides et des tests de laboratoire."
}
},
{
"@type": "Question",
"name": "Comment détecter une infection à VIH ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins spécifiques détectent les anticorps ou l'ARN du VIH."
}
},
{
"@type": "Question",
"name": "Quels symptômes de la dengue ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleurs articulaires, éruptions cutanées et fatigue sont fréquents."
}
},
{
"@type": "Question",
"name": "Quels signes du paludisme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, frissons, sueurs, maux de tête et douleurs musculaires sont typiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes de la tuberculose ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Toux persistante, perte de poids, sueurs nocturnes et fatigue sont courants."
}
},
{
"@type": "Question",
"name": "Quels signes du choléra ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Diarrhée aqueuse sévère, vomissements et déshydratation rapide sont caractéristiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une infection à VIH ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Symptômes initiaux incluent fièvre, fatigue, éruptions cutanées et ganglions enflés."
}
},
{
"@type": "Question",
"name": "Comment prévenir la dengue ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éliminer les eaux stagnantes et utiliser des répulsifs contre les moustiques."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour prévenir le paludisme ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des moustiquaires, des insecticides et prendre des médicaments préventifs."
}
},
{
"@type": "Question",
"name": "Comment prévenir la tuberculose ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vaccination BCG et dépistage des cas contacts sont essentiels pour la prévention."
}
},
{
"@type": "Question",
"name": "Quelles précautions contre le choléra ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Boire de l'eau potable, se laver les mains et consommer des aliments cuits."
}
},
{
"@type": "Question",
"name": "Comment prévenir le VIH ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des préservatifs et se faire dépister régulièrement pour prévenir le VIH."
}
},
{
"@type": "Question",
"name": "Quel traitement pour la dengue ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement est symptomatique, avec des analgésiques et une hydratation adéquate."
}
},
{
"@type": "Question",
"name": "Comment traiter le paludisme ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments antipaludiques comme l'artémisinine sont utilisés pour traiter le paludisme."
}
},
{
"@type": "Question",
"name": "Quel traitement pour la tuberculose ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La tuberculose nécessite un traitement antibiotique prolongé, souvent sur six mois."
}
},
{
"@type": "Question",
"name": "Comment traiter le choléra ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le choléra est traité par réhydratation orale ou intraveineuse et antibiotiques si nécessaire."
}
},
{
"@type": "Question",
"name": "Quel traitement pour le VIH ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le VIH est traité par des antirétroviraux pour contrôler la charge virale."
}
},
{
"@type": "Question",
"name": "Quelles complications de la dengue ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la dengue sévère, le choc et des hémorragies."
}
},
{
"@type": "Question",
"name": "Quelles complications du paludisme ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le paludisme peut entraîner des anémies, des convulsions et des défaillances organiques."
}
},
{
"@type": "Question",
"name": "Quelles complications de la tuberculose ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la dissémination à d'autres organes et la résistance aux médicaments."
}
},
{
"@type": "Question",
"name": "Quelles complications du choléra ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La déshydratation sévère peut entraîner un choc hypovolémique et la mort."
}
},
{
"@type": "Question",
"name": "Quelles complications du VIH ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le VIH peut mener à des infections opportunistes et à des cancers associés."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la dengue ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vivre dans des zones tropicales, exposition aux moustiques et manque d'assainissement."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le paludisme ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vivre dans des zones endémiques, absence de protection contre les moustiques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la tuberculose ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Conditions de vie précaires, immunodépression et contact avec des malades."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le choléra ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Accès limité à l'eau potable et à l'assainissement, ainsi que la consommation d'aliments contaminés."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le VIH ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Relations sexuelles non protégées, partage de seringues et absence de dépistage."
}
}
]
}
]
}
Neurodegenerative diseases are a class of disorders linked to the formation in the nervous system of fibrillar protein aggregates called amyloids. This aggregation process is affected by a variety of ...
The innate immune response is the first-line host defense against pathogens. Cytosolic nucleic acids, including both DNA and RNA, represent a special type of danger signal to initiate an innate immune...
Amino acid substitutions and post-translational modifications (PTMs) play a crucial role in many cellular processes by directly affecting the structural and dynamic features of protein interaction. De...
Nascent chains undergo co-translational enzymatic processing as soon as their N-terminus becomes accessible at the ribosomal polypeptide tunnel exit (PTE). In eukaryotes, N-terminal methionine excisio...
Drug transporters are modulators for drug absorption, distribution, and excretion. Key drug transporters including P-glycoprotein and breast cancer resistance protein of the ABC superfamily; organic a...
Facioscapulohumeral muscular dystrophy (FSHD) is caused by abnormal de-repression of the myotoxic transcription factor DUX4. Although the transcriptional targets of DUX4 are known, the regulation of D...
We immunoprecipitated DUX4 protein and performed mass spectrometry to identify PTMs. We then characterized DUX4 PTMs and potential enzyme modifiers using mutagenesis, proteomics, and biochemical assay...
We identified 17 DUX4 amino acids with PTMs, and generated 55 DUX4 mutants designed to prevent or mimic PTMs. Five mutants protected cells against DUX4-mediated toxicity and reduced the ability of DUX...
These results support that DUX4 is regulated by PTMs and set a foundation for developing FSHD drug screens based mechanistically on DUX4 PTMs and modifying enzymes. ANN NEUROL 2023;94:398-413....
In this review, we extensively describe the main post-translational modifications that give rise to the multiple proteoforms characterized to date in the human salivary proteome and their potential ro...
The post-translational modifications of conopeptides are the most complicated modifications to date and are well-known and closely related to the activity of conopeptides. The hydroxylation of proline...
Post-translational modifications (PTMs) play key roles in regulating cell signaling and physiology in both normal and cancer cells. Advances in mass spectrometry enable high-throughput, accurate, and ...
Post-translational modifications (PTMs) are chemical modifications that can regulate the activity and function of proteins. From an evolutionary perspective, they also represent a fast mechanism for t...